AlphaFold2 versus experimental structures: evaluation on G protein-coupled receptors
GPCR News
Pharmacophore-guided Virtual Screening to Identify New β 3 -adrenergic Receptor Agonists
RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. Lübeck, Germany...
SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...
Molecular targets of psychedelic-induced plasticity
Molecular insights into psychedelic drug action
Multifunctional role of GPCR signaling in epithelial tube formation
Trevena Reports Second Quarter 2022 Results and Provides Business Update
The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9β1 and α4β1
GRK2 selectively attenuates the neutrophil NADPH-oxidase response triggered by β-arrestin recruiting
A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology in...
2nd IRN i-GPCRnet, September 30 to October 1st, 2022. University of Wurzburg, Germany
Effects of Small Molecule Ligands on ACKR3 Receptors
Community guidelines for GPCR ligand bias: IUPHAR review 32
A new Kunitz-type snake toxin family associated with an original mode of interaction with the...
Discovery of 3(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligand
Actions of Parathyroid Hormone Ligand Analogues in Humanized PTH1R Knockin Mice
RGS7-ATF3-Tip60 Complex Promotes Hepatic Steatosis and Fibrosis by Directly Inducing TNFα
Aβ peptides stabilize GPCRs in inactive form and trigger inverse agonism in Alzheimer's disease
GPR110, a receptor for synaptamide, expressed in osteoclasts negatively regulates osteoclastogenesis